Following two FDA rejections and two sell signals, it's time to cash out of Gilead Sciences. More
20 Dividend Stocks I Purchased for my IRA Rollover
I recently rolled 401k funds into an IRA and decided to distribute the funds into 20 dividend stocks: here are my picks for the IRA More
Life Insurers Are Dead in the Water
These stocks need subscriber growth and higher interest rates -- and those are nowhere to be found. I'd avoid this industry amid looming earnings. More
Pitney Bowes Takes the Plunge
Pitney Bowes' deteriorating business finally took a bite out of PBI's 2013 renaissance, with poor earnings and a massive dividend cut sparking a Tuesday selloff. More
Warren Buffett’s Biggest Mistake
Warren Buffett has a reputation for being open about his strategies, successes and failures. But his worst investment might surprise you. More
